Sign in to view content

Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Efficacy, Safety, and Durability Results From the Phase 3 TENAYA and LUCERNE Trials

Arshad M. Khanani, MD, MA, FASRS

Video
Published 2022

Related

Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 3 Archway Trial
Peter A. Campochiaro, MD
Updates from the Field
2021
Potential Safety Concerns of Bevacizumab
Robert L. Avery, MD
Updates from the Field
2017
Prognostic Value of Subretinal Hyperreflective Material
Russell Pokroy, MD
Updates from the Field
2017

Category: wet AMD

See more